Obesity Drug Case Study Links Man's Heart Problems With Extreme Weight Loss

United States News News

Obesity Drug Case Study Links Man's Heart Problems With Extreme Weight Loss
United States Latest News,United States Headlines
  • 📰 ScienceAlert
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 68%

The Best in Science News and Amazing Breakthroughs

A case study of a 62-year-old man in the US provides a prime example of why it's so important to keep a close eye on

Consequently his family doctor prescribed him with daily insulin injections, as well as a daily dose of a thyroid hormone replacement drug calledby 39 kg , or almost 30 percent of his body weight, in just six months. All of this could have been prevented if the man had adjusted his other medications in relation to his changing weight. The levothyroxine should have been adjusted as his weight changed to avoid the thyrotoxicosis and atrial fibrillation, according to the case study authors.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ScienceAlert /  🏆 63. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

A Man’s Rapid Weight Loss From Obesity Drug Led to Heart ProblemsA Man’s Rapid Weight Loss From Obesity Drug Led to Heart ProblemsA case report highlights the danger of mixing certain medications with the newest generation of weight-loss drugs.
Read more »

Study evaluates treatment interventions for severe obesity in adolescentsStudy evaluates treatment interventions for severe obesity in adolescentsAdolescents with severe obesity who received meal-replacement therapy plus financial incentives experienced a greater reduction in body mass index compared to those who received meal replacement therapy alone, according to recent findings.
Read more »

Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from RocheNovo Nordisk and Eli Lilly shares slide on new obesity drug trial from RocheNovo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche’s latest obesity drug candidate.
Read more »

Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from RocheNovo Nordisk and Eli Lilly shares slide on new obesity drug trial from RocheNovo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche's latest obesity drug candidate.
Read more »

UT Health San Antonio study: HIV drug might slow Alzheimer’sAfter a limited clinical trial, the research team hopes to perform a yearlong study to better test the findings.
Read more »

Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage studyEli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage studyThe data adds to mounting evidence that Zepbound and other popular GLP-1 drugs have health benefits beyond promoting weight loss and regulating blood sugar.
Read more »



Render Time: 2025-02-13 01:19:30